A pilot study on the usefulness of a vital sign monitoring using heart rate variability analysis in assessing the physical function of patients with terminal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1030240433

Enrollment

Registered

2024-10-25

Start date

2024-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Terminal cancer

Interventions

From the day consent is obtained until the day of discharge, a wearable heart rate sensor device will be attached to the left anterior chest of each study participant, and heart rate data will be coll

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Prognosis predicted by the Palliative Prognostic Index is likely to be 21 days or less 2. Written informed consent is obtained

Exclusion criteria

Exclusion criteria: 1. With arrhythmias affecting the R-R interval 2. Cardiac pacemaker being fitted 3. Other conditions judged as inappropriate for the study by the investigator

Design outcomes

Primary

Measure	Time frame
Correlation between prognosis and autonomic nervous activity measured by heart rate variability	—

Contacts

Public ContactTetsushi Tsuruga

Tokyo Metropolitan Komagome Hospital

tsurugatetsushi@gmail.com+81-3-3823-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026